IL43022A - Pharmaceutical preparation for oral use containing cholestyramine quercet - Google Patents

Pharmaceutical preparation for oral use containing cholestyramine quercet

Info

Publication number
IL43022A
IL43022A IL43022A IL4302273A IL43022A IL 43022 A IL43022 A IL 43022A IL 43022 A IL43022 A IL 43022A IL 4302273 A IL4302273 A IL 4302273A IL 43022 A IL43022 A IL 43022A
Authority
IL
Israel
Prior art keywords
composition
hydrophil
colloid
cellulose
pharmaceutical composition
Prior art date
Application number
IL43022A
Other languages
English (en)
Hebrew (he)
Other versions
IL43022A0 (en
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of IL43022A0 publication Critical patent/IL43022A0/xx
Publication of IL43022A publication Critical patent/IL43022A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/74Synthetic polymeric materials
    • A61K31/785Polymers containing nitrogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
IL43022A 1972-09-01 1973-08-20 Pharmaceutical preparation for oral use containing cholestyramine quercet IL43022A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28571972A 1972-09-01 1972-09-01

Publications (2)

Publication Number Publication Date
IL43022A0 IL43022A0 (en) 1974-01-14
IL43022A true IL43022A (en) 1976-07-30

Family

ID=23095432

Family Applications (1)

Application Number Title Priority Date Filing Date
IL43022A IL43022A (en) 1972-09-01 1973-08-20 Pharmaceutical preparation for oral use containing cholestyramine quercet

Country Status (7)

Country Link
CA (1) CA1014472A (de)
DE (1) DE2344090A1 (de)
FR (1) FR2197592B1 (de)
GB (1) GB1446352A (de)
IL (1) IL43022A (de)
NL (1) NL7311319A (de)
ZA (1) ZA736016B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4914084A (en) * 1984-05-09 1990-04-03 Synthetic Blood Corporation Composition and method for introducing heme, hemoproteins, and/or heme-hemoprotein complexes into the body
US4804548A (en) * 1984-10-05 1989-02-14 Warner-Lambert Company Novel sweetener delivery systems
US4797288A (en) * 1984-10-05 1989-01-10 Warner-Lambert Company Novel drug delivery system
US4828857A (en) * 1984-10-05 1989-05-09 Warner-Lambert Company Novel sweetener delivery systems
US4818539A (en) * 1985-02-05 1989-04-04 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4851392A (en) * 1985-02-05 1989-07-25 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4790991A (en) * 1985-02-05 1988-12-13 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4747881A (en) * 1985-02-05 1988-05-31 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
US4843098A (en) * 1985-02-05 1989-06-27 Warner-Lambert Company Ingestible aggregate and delivery system prepared therefrom
IT1190349B (it) * 1986-06-16 1988-02-16 Prodotti Formenti Srl Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
US5167965A (en) * 1987-02-09 1992-12-01 The Dow Chemical Company Palatable cholestyramine granules, tablets and methods for preparation thereof
DE68903605T2 (de) * 1988-05-04 1993-04-01 Smith Kline French Lab Kautablette.
US4931280A (en) * 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine
US5275823A (en) * 1989-04-27 1994-01-04 Smith Kline & French Laboratories Ltd. Pharmaceutical compositions
US5102664A (en) * 1989-07-19 1992-04-07 Day Charles E Good-tasting gritty drug formulations
BR9107174A (pt) * 1990-12-20 1993-11-16 Procter & Gamble Composicoes de psyllium e colestiramina com palatabilidade aperfeicoada
AU3812893A (en) * 1992-03-20 1993-10-21 Procter & Gamble Company, The Anion exchange resin compositions

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3499960A (en) * 1965-01-25 1970-03-10 Merck & Co Inc Palatable coated particles of an anion exchange resin

Also Published As

Publication number Publication date
IL43022A0 (en) 1974-01-14
FR2197592A1 (de) 1974-03-29
DE2344090A1 (de) 1974-03-21
FR2197592B1 (de) 1976-08-13
CA1014472A (en) 1977-07-26
NL7311319A (de) 1974-03-05
ZA736016B (en) 1975-04-30
GB1446352A (en) 1976-08-18
AU5946073A (en) 1975-02-27

Similar Documents

Publication Publication Date Title
IL43022A (en) Pharmaceutical preparation for oral use containing cholestyramine quercet
GB1507521A (en) Dosage unit
PH23698A (en) Sustained release compositions comprising hydroxypropyl cellulose ethers
GR3020008T3 (en) Process for preparing mechanically stable, well disintegrating tablets from small active agent containing solid forms
ATE17650T1 (de) Trockenpulverisierte n-acetyl-p-aminophenolzusammensetzungenund verfahren zu deren herstellung.
IL46252A0 (en) New araliphatic ketones and alcohols,their preparation and pharmaceutical compositions containing them
GB1385285A (en) Pharmaceutical capsule wall materials
GB1001481A (en) Improvements in or relating to materials containing ion-exchange groups
EP0331385A2 (de) Wässrige Sucralfate-Suspension
GB1235801A (en) A process for the manufacture of rapidly-disintegrating solid dosage unit forms
GB1464200A (en) Pharmaceutical composition
IL57599A (en) Indole derivatives,their preparation and pharmaceutical compositions comprising them
GB1072021A (en) Substituted hydroxypropyl celluloses
GB1383724A (en) Process for the preparation of powdered maltitol
IE40946B1 (en) A 4-0- -d-glucopyranosyl-6-0- , d-xylohexopyranosyl-2-deoxystreptamine, process for its preparation, and compositions incorporating it
GB1297221A (de)
CA991184A (fr) Derives de l'isoindoline, leur preparation et les compositions medicinales qui les contiennent
FR2175853A1 (en) Oral cmpns for tobacco dependence - contg avena extracts dispersing rapidly in the mouth
AU476979B2 (en) 4'-alkoxyalkyleneoxy-5-benzylpyrimidines, their preparation and pharmaceutical compositions thereof
EG12459A (en) A sex attractant composition comprising as active component tetradeca-9,11 dienyl acetate
IL34086A0 (en) Triazole derivatives,their preparation and pharmaceutical compositions containing them
GB1407132A (en) Cellulosic materials
AU2009970A (en) Novel pharmaceutically active 4_acylamino-1,2,4-triazol derivatives and a process for their preperation
GB1055648A (en) Improved adhesive composition
IL43761A0 (en) Tetrazole derivatives of chromonyloxy-phenoxypropanes,their preparation and pharmaceutical compositions containing them